Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass - PubMed (original) (raw)
Comparative Study
. 1993 Nov;88(5 Pt 1):2128-38.
doi: 10.1161/01.cir.88.5.2128.
Affiliations
- PMID: 8222107
- DOI: 10.1161/01.cir.88.5.2128
Comparative Study
Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass
D L Wessel et al. Circulation. 1993 Nov.
Abstract
Background: Increased pulmonary vascular resistance is common in congenital heart disease and is exacerbated by cardiopulmonary bypass (CPB). We investigated whether CPB is responsible for pulmonary endothelial dysfunction and contributes to postoperative pulmonary hypertension.
Methods and results: We infused the endothelium-dependent vasodilator acetylcholine (ACH) into the pulmonary circulation of pulmonary hypertensive children with congenital heart disease either before (n = 12) or after (n = 22) surgical repair on CPB. The dose response to ACH (10(-9) to 10(-6) M) was recorded for all hemodynamic variables. Nine additional postoperative patients were studied with ACH followed by inhalation of 80 ppm nitric oxide, an endothelium-independent smooth muscle relaxant. Plasma levels of cyclic GMP (cGMP) were measured before and after ACH and nitric oxide administration. Pulmonary vasodilation with 10(-6) M ACH was seen in all preoperative patients but was markedly attenuated in postoperative patients. Baseline pulmonary vascular resistance (5.6 +/- 1.0 U x m2) fell 46 +/- 5% in preoperative patients but declined only 11 +/- 4% from baseline (5.8 +/- 0.9 U x m2) in postoperative patients (P < .002). However, inhalation of 80 ppm nitric oxide after ACH infusion in postoperative patients lowered pulmonary vascular resistance by 33 +/- 4% (P < .0002 compared with postoperative ACH response) with minimal effects on the systemic circulation. This finding suggests that the capacity for smooth muscle relaxation and pulmonary vasodilation was present in postoperative patients but could not be induced by ACH. Plasma levels of cGMP in postoperative patients were unchanged after acetylcholine infusion but rose more than threefold during pulmonary vasodilation with nitric oxide (P < .0001). This finding is consistent with the purported role of cGMP as the second messenger effecting smooth muscle relaxation in this process.
Conclusions: CPB may be responsible for postoperative dysfunction of the pulmonary endothelial cell and may contribute to postoperative pulmonary hypertension in children. Inhaled nitric oxide is a potent pulmonary vasodilator after CPB with minimal systemic circulatory effects. It may have important diagnostic and therapeutic applications in patients with congenital heart disease.
Similar articles
- The influences of NO and Ach on cGMP levels in two patient populations.
Jiang Z, Lei Y, Gu K, Xianghua J, Liming X, Kejian H. Jiang Z, et al. J Extra Corpor Technol. 2001 Feb;33(1):23-6. J Extra Corpor Technol. 2001. PMID: 11315129 - Exhaled nitric oxide before and after cardiac surgery with cardiopulmonary bypass--response to acetylcholine and nitroglycerin.
Törnberg DC, Angdin M, Settergen G, Liska J, Lundberg JO, Weitzberg E. Törnberg DC, et al. Br J Anaesth. 2005 Feb;94(2):174-80. doi: 10.1093/bja/aei027. Epub 2004 Nov 12. Br J Anaesth. 2005. PMID: 15542536 - Effects of cardiopulmonary bypass and circulatory arrest on endothelium-dependent vasodilation in the lung.
Kirshbom PM, Jacobs MT, Tsui SS, DiBernardo LR, Schwinn DA, Ungerleider RM, Gaynor JW. Kirshbom PM, et al. J Thorac Cardiovasc Surg. 1996 Jun;111(6):1248-56. doi: 10.1016/s0022-5223(96)70228-3. J Thorac Cardiovasc Surg. 1996. PMID: 8642827 - Clinical applications of inhaled nitric oxide in children with pulmonary hypertension.
Wessel DL, Adatia I. Wessel DL, et al. Adv Pharmacol. 1995;34:475-504. doi: 10.1016/s1054-3589(08)61104-7. Adv Pharmacol. 1995. PMID: 8562453 Review. - Inhaled nitric oxide in the neonate with cardiac disease.
Atz AM, Wessel DL. Atz AM, et al. Semin Perinatol. 1997 Oct;21(5):441-55. doi: 10.1016/s0146-0005(97)80009-2. Semin Perinatol. 1997. PMID: 9352616 Review.
Cited by
- Physiological reactions of nitric oxide and hemoglobin: a radical rethink.
Gross SS, Lane P. Gross SS, et al. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):9967-9. doi: 10.1073/pnas.96.18.9967. Proc Natl Acad Sci U S A. 1999. PMID: 10468537 Free PMC article. Review. No abstract available. - Severe paediatric pulmonary hypertension: new management strategies.
Rashid A, Ivy D. Rashid A, et al. Arch Dis Child. 2005 Jan;90(1):92-8. doi: 10.1136/adc.2003.048744. Arch Dis Child. 2005. PMID: 15613526 Free PMC article. Review. - The pharmacology of inhaled nitric oxide.
Edwards AD. Edwards AD. Arch Dis Child Fetal Neonatal Ed. 1995 Mar;72(2):F127-30. doi: 10.1136/fn.72.2.f127. Arch Dis Child Fetal Neonatal Ed. 1995. PMID: 7712273 Free PMC article. Review. No abstract available. - Pulmonary hypertension in lambs transfused with stored blood is prevented by breathing nitric oxide.
Baron DM, Yu B, Lei C, Bagchi A, Beloiartsev A, Stowell CP, Steinbicker AU, Malhotra R, Bloch KD, Zapol WM. Baron DM, et al. Anesthesiology. 2012 Mar;116(3):637-47. doi: 10.1097/ALN.0b013e318246ef77. Anesthesiology. 2012. PMID: 22293717 Free PMC article. - Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure.
Costello JM, Backer CL, Checchia PA, Mavroudis C, Seipelt RG, Goodman DM. Costello JM, et al. Pediatr Cardiol. 2004 Jul-Aug;25(4):347-53. doi: 10.1007/s00246-003-0512-5. Pediatr Cardiol. 2004. PMID: 14735254
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical